| 臺大學術典藏 |
2020-11-03T12:12:33Z |
Generation of a human induced pluripotent stem cell (iPSC) line (IBMS-iPSC-048-05) from a patient with ALS and parkinsonism having a hexanucleotide repeat expansion mutation in C9orf72 gene
|
Lin H.-Y.;Tsai L.-K.;Cheng Y.-C.;Lu H.-E.;Huang C.-Y.;Hsieh P.C.H.;Chin-Hsien Lin; Lin H.-Y.; Tsai L.-K.; Cheng Y.-C.; Lu H.-E.; Huang C.-Y.; Hsieh P.C.H.; CHIN-HSIEN LIN |
| 臺大學術典藏 |
2020-03-04T07:45:31Z |
Generation of induced pluripotent stem cells from a patient with Parkinson's disease carrying LRRK2 p.I2012T mutation
|
CHIN-HSIEN LIN; Cheng Y.-C.; Lin H.-I.; Ho M.-C.; Hsu Y.-H.; Wen C.-H.; Ko H.-W.; Lu H.-E.; Huang C.-Y.; Hsieh P.C.H. |
| 臺大學術典藏 |
2020-03-04T07:45:30Z |
Generation of induced pluripotent stem cells (IBMSi011-A) from a patient with Parkinson's disease carrying LRRK2 p.I1371V mutation
|
Lin H.-I.; Cheng Y.-C.; Ko H.-W.; Wen C.-H.; Lu H.-E.; Huang C.-Y.; Hsieh P.C.H.; CHIN-HSIEN LIN |
| 臺大學術典藏 |
2020-03-04T07:45:30Z |
Reprogramming of a human induced pluripotent stem cell (iPSC) line (IBMSi012-A) from an early-onset Parkinson's disease patient harboring a homozygous p.D331Y mutation in the PLA2G6 gene
|
Cheng Y.-C.; Lin H.-I.; Syu S.-H.; Lu H.-E.; Huang C.-Y.; CHIN-HSIEN LIN; Hsieh P.C.H. |
| 臺大學術典藏 |
2020-03-04T07:45:30Z |
Generation of 2 induced pluripotent stem cell lines derived from patients with Parkinson's disease carrying LRRK2 G2385R variant
|
Hsu Y.-H.; Syu S.-H.; Lu H.-E.; Lin H.-I.; CHIN-HSIEN LIN; Hsieh P.C.H.; Huang C.-Y.; Ho M.-C.; Cheng Y.-C. |
| 臺大學術典藏 |
2020-02-17T07:43:28Z |
Generation of induced pluripotent stem cell line-NTUHi001-A from a premature ovarian failure patient with Turner's syndrome mosaicism
|
Lu C.-Y;Chen Y.-A;Syu S.-H;Lu H.-E;Hong-Nerng Ho;Chen H.-F.; Lu C.-Y; Chen Y.-A; Syu S.-H; Lu H.-E; HONG-NERNG HO; Chen H.-F. |
| 臺大學術典藏 |
2020 |
Generation of a human induced pluripotent stem cell (iPSC) line (IBMS-iPSC-048-05) from a patient with ALS and parkinsonism having a hexanucleotide repeat expansion mutation in C9orf72 gene
|
Lu H.-E.; Huang C.-Y.; Hsieh P.C.H.; Lin C.-H.; Lin H.-Y.; Cheng Y.-C.; LI-KAI TSAI; Lin H.-Y.;Li-Kai Tsai;Cheng Y.-C.;Lu H.-E.;Huang C.-Y.;Hsieh P.C.H.;Lin C.-H. |
| 國立成功大學 |
2020 |
Copy number variant hotspots in Han Taiwanese population induced pluripotent stem cell lines - Lessons from establishing the Taiwan human disease iPSC Consortium Bank
|
Huang, C.-Y.;Li, Li L.-H.;Hsu, W.-T.;Cheng, Y.-C.;Nicholson, M.W.;Liu, C.-L.;Ting, C.-Y.;Ko, H.-W.;Syu, Syu S.-H.;Wen, C.-H.;Yan, Z.;Huang, Huang H.-P.;Su, H.-L.;Chiang, P.-M.;Shen, C.-N.;Chen, H.-F.;Yen, B.L.J.;Lu, H.-E.;Hwang, S.-M.;Chiou, S.-H.;Ho, Ho H.-N.;Wu, J.-Y.;Kamp, T.J.;Wu, J.C.;Hsieh, P.C.H. |
| 臺大學術典藏 |
2017 |
Generation of induced pluripotent stem cells from a patient with Parkinson's disease carrying LRRK2 p.I2012T mutation
|
Lu H.-E.; Ko H.-W.; Wen C.-H.; Hsu Y.-H.; Ho M.-C.; Lin H.-I.; Cheng Y.-C.; CHIN-HSIEN LIN; Chin-Hsien Lin;Cheng Y.-C.;Lin H.-I.;Ho M.-C.;Hsu Y.-H.;Wen C.-H.;Ko H.-W.;Lu H.-E.;Huang C.-Y.;Hsieh P.C.H.; Huang C.-Y.; Hsieh P.C.H. |
| 國立東華大學 |
2007 |
THE UNDERLYING MECHANISMS OF ENHANCED ISCHEMIC STROKE DAMAGE FOLLOWED BY HIGH-FAT FED TYPE II DIABETES.
|
Weng, C. F.; Lu, H. E.; Hsieh, K. H.; Jhao, S. S.; Liao, C. H.; Lin, S. Z. |
